Eurasian Journal of Medical and Natural Sciences 5-jild 2-son (2025) · 105–110-betlar

RIVASTIGMINE IN DEMENTIA THERAPY: EXPANDING THERAPEUTIC POTENTIAL FROM COGNITIVE CORRECTION TO NEURON PROTECTION

Yusupov, Shokhzod, Jabborova, Zamira, Yuldoshev, Jaloliddin, Abdikodirov, Botir, Kasimov, Arslanbek

DOI: 10.5281/zenodo.14850896 · Manbada o'qish →

Annotatsiya

Dementia is one of the most significant medical and social problems of modern society, which is caused by a steady increase in morbidity associated with an increase in the life expectancy of the population. According to the World Health Organization, there are more than 55 million people with dementia worldwide, and that number could triple by 2050. In these conditions, the search for effective therapies that can not only alleviate the symptoms of the disease, but also influence its pathogenetic mechanisms, becomes particularly relevant.

Rivastigmine, dementia, neuroprotection, cholinesterase inhibitors, cognitive impairment, Alzheimer's disease, neurodegeneration, cholinergic system, synaptic plasticity, neuroinflammation.

Metadata manbasi: jurnal OAI-PMH arxivi · Sindex to'liq matnni saqlamaydi, manbaga havola beradi.